Credo Technology Group Holding Ltd shares have been dropping, down 30%+ from recent highs. Learn more about CRDO stock here.

Palantir is a Strong Buy ahead of Q2 earnings as revenue and profits surge, commercial growth accelerates, and valuation ...

British American Tobacco is rated a Buy; transitioning into next-generation nicotine products is key. Read more on BTI stock ...

Key 2026 catalysts include the trastuzumab pamirtecan BLA filing, pivotal Phase 3 oncology readouts, and a binary EPO patent ...

Qure N.V. downgraded to Hold as AMT-130 faces FDA uncertainty; BLA targeted Q3 2026 with key data due Sept 2026. Click for ...

BTSG stock plunged 18% after Q2 earnings. See BrightSpring’s EPS/revenue beat, raised 2026 guidance, valuation concerns and ...

Tilray (TLRY) stock jumps after Q4 earnings: revenue beat, BrewDog-driven beverage growth, and FY2027 EBITDA guidance.

Search/Cloud growth and +30% operating income, but FCF turns negative as capex surges. Click here to read my latest analysis.

Adaptive Biotechnologies (ADPT) pivots to pure-play MRD diagnostics as clonoSEQ adoption, margins & backlog surge.

TOYO is upgraded to Buy after a 60% stock decline post-dilutive equity raise, as operational momentum remains robust. Read ...

PIMCO Dynamic Income Fund analysis: 16.4% yield vs. NAV erosion, weak coverage, leverage, and rate risk. Click here to read ...

WisdomTree Cloud Computing Fund ETF is currently fairly valued, making it suitable for hedging against undervalued software ...